Objective-To compare general practitioners' prescribing costs in fundholding and non-fundholding practices before and after implementation of the NHS reforms in April 1991.
increases in prescribing costs, even among dispensing general practitioners, for whom the incentives are different. Indicative prescribing amounts for non-fundholding practices do not seem to have had the same effect.
prescribing costs: indicative prescribing amounts for non-fundholding general practices and prescribing budgets for fundholding practices. Family health services authorities were responsible for setting indicative prescribing amounts based on previous spending adjusted for price rises and changes in product mix, expected changes in the size of a practice's population, changes in the number of patients who require expensive drugs, and the average amount spent in comparable practices in the authority. They were expected to monitor what was spent against indicative amounts and to encourage cost effective prescribing. 2 An incentive scheme for non-fundholders was also proposed: if a majority of practices in a family health services authority could agree planned savings the authority was allowed to keep half of the savings for "schemes of improvement in primary health care in their areas as agreed with their general practitioners."' This scheme, however, did not attract much interest and none of the family health services authorities in the Oxford region took part in it.
Fundholders' drugs budgets were calculated on the same basis as indicative precribing amounts, with additional adjustments for discounts and container costs to convert the indicative amount into a cash budget. The budgets were cash limited and any savings made could either be transferred into another budget category-for example, hospital services-or spent on improving patient care in the next financial year. These budgets offered a more direct incentive to general practitioners to save money.
The effects of these two initiatives need to be properly compared and evaluated. In this paper we report some results from a study designed to evaluate the impact of the NHS reforms on general practices in the Oxford region. We have collected data from first wave fundholding practices and non-fundholding practices in the year before and the year after the 1991 reorganisation to measure the effect of the NHS reforms on outpatient referral rates, inpatient admissions, prescribing patterns, and practice based facilities. This paper reports the general practitioners' prescribing patterns and costs.
Introduction
The total cost of NHS prescriptions dispensed by pharmacists and appliance contractors in the United Kingdom in 1991 was over £3000m. This figure represented an average cost of £55 per person and was the largest single element of the family health services authorities' budget. In the past decade there has been a rise, after inflation, of 56% in the net costs of ingredients and 26% in the number ofitems prescribed. ' The government saw these escalating drug costs as a priority to be addressed in its reorganisation of the NHS and introduced two initiatives designed to provide general practitioners with incentives to reduce Methods Prescribing analysis and cost (PACT) data, levels 2 and 3, were obtained for two six month periods in 1990-1 (phase 1) and in 1991-2 (phase 2) for eight fundholding and seven non-fundholding practices. These practices included all but two ofthose which had participated in a previously reported referral study. 4 The remaining two practices were excluded because their family health services authority was unable to supply PACT data for the relevant six months of phase 1 .
The aim was to monitor changes in prescribing costs, the number of items prescribed, and the propor-tion of generic drugs prescribed over the two time periods in three groups of practices-non-dispensing, non-fundholding practices; non-dispensing, fundholding practices; and dispensing fundholding practices. The dispensing practices were analysed separately because the incentives for dispensing general practitioners are different in that they retain the profits from their dispensary.5 Additionally, there were no dispensing practices among the non-fundholding group.
The total population registered with the practices taking part in the study was 208 398. Practice populations ranged from 6255 to 24 008, with a mean of 13 739 in the fundholding practices and of 14227 in the non-fundholding practices. Six of the eight fundholding practices and six of the seven non-fundholding practices were training practices. All but one nonfundholding practice had computers. None of the practices were in deprived areas and none received a deprivation allowance for any of their patients.
Results are expressed as a six monthly rate per 1000 prescribing units. Prescribing units are used in PACT data as a crude means of adjusting for age. They are based on the assumption that older patients receive on average three times as many prescriptions as other patients and, since the number of elderly patients in a practice varies, the denominator is the number of prescribing units rather than the practice population.
Details of indicative prescribing amounts and fundholders' drugs budgets were obtained so that the budget and the amount spent at the end of the year could be compared. Questionnaires were sent to all participating practices asking whether they had used any formularies or prescribing protocols before the 1991 reorganisation, whether any formularies or prescribing protocols had been introduced during the first year of the reforms, and whether the practice had sought pharmaceutical advice either from the family health services authority or from the regional health authority.
Results
The dispensing fundholders had the highest total net cost of ingredients in the first phase ofthe study but the lowest in the second phase, despite an increase of 10-2% between the two periods (table I). The net costs of ingredients increased more steeply among the non-dispensing practices. The greatest increase occurred in prescribing for diseases of the central nervous system and the smallest in prescribing for musculoskeletal problems.
All groups increased the number of items prescribed (table II) , and the average cost per item also increased in all three groups (table III). The percentage of generic drugs prescribed increased significantly in 
Discussion
One of the main attractions of the fundholding scheme for the practices which volunteered to join it was the opportunity to make budgetary savings in certain aspects of their clinical practice which could be reinvested in other aspects of patient care. It has always been apparent that the drugs element of fundholders' budgets offered the greatest potential for savings. Our study provides evidence that this scheme has indeed had an effect on prescribing costs.
Before the reforms the group of non-fundholding practices had the lowest total net cost of ingredients, the lowest number of items prescribed, and the highest percentage of generic drugs prescribed of the three groups. In terms of costs they were reasonably representative of local practices: only three of the seven were below the average level of spending in their family health services authority. By phase 2 their costs were BMJ VOLUME 307 higher than those of the fundholding practices. The financial incentives offered by the fundholding scheme proved to be more effective than the much weaker incentives to change prescribing patterns available to non-fundholders. It will be interesting to see whether the newer individual practice incentive schemes will have more effect. 8 Historically, prescribing in general practice has been the main non-cash limited element in the NHS budget, and there were few incentives to restrict costs. The introduction of fundholding brings a proportion of prescribing costs within the cash limited budget; in the long run fundholding may reduce the national drugs bill, which has been growing by around 11% each year since 1987.9 It increased by 12-3% during this study. Hospitals are tending to shift the costs of prescribing on to general practices, but we found no evidence of a differential effect on fundholders and non-fundholders.
The scope for reducing the number and cost of prescriptions issued without detriment to good patient care is believed to be considerable,8'0 so it was no surprise to find that many fundholding practices succeeded in making savings in their drugs budgets. However, these savings were not as large as the government might have hoped. Despite adopting several measures designed to rationalise their prescribing, none of the practices in our study was able to achieve a reduction in the net costs of ingredients. The fact that five fundholding practices were nevertheless able to make savings suggests that their drugs budgets were allocated generously. Fundholders took full advantage of the opportunity to negotiate various increases to their budgets, and the additions that were subject to the discretion of medical advisers to the family health services authorities varied considerably. This variation may have been appropriate as the aim was a flexible process of budget allocation taking "full account of the needs and circumstances of each practice,"" but the process could be perceived as unfair by those who were not able to benefit from it by reinvesting the savings. The solution to this problem would be a revised system of budget allocation based on a needs weighted capitation formula, but the construction of a satisfactory formula is proving difficult. 12 In conclusion, our study shows that general practitioners will modify their prescribing behaviour if offered sufficiently clear incentives. A true test of these reforms, however, will be to show that they lead to improvements in the efficiency, effectiveness, and equitable distribution of health care resources. As we Practice implications * General practitioners' prescribing costs have risen in real terms by 56% in the past decade * Indicative prescribing schemes for non-fundholders and drug budgets for fundholders were introduced in the 1991 reforms as incentives to curb these increases * This study found that in the year after implementation of these schemes fundholders had significantly lower increases in drug costs than non-fundholders * Dispensing and non-dispensing fundholders increased the percentage of generic drugs that they prescribed whereas the non-fundholders did not * Over 60% of the fundholding practices in the study made 
COPING WITH CHANGE IN GENERAL PRACTICE
It would be comforting if all the changes required in general practice were based on reliable evidence from good empirical research. In the case of the new general practitioners' contract the evidence was either lacking or pointed in directions quite different from those proposed by the contract. Often, however, the evidence is simply not available, or is confused. We would argue, for example, that even in the absence of hard evidence counselling reduces morbidity or improves prognosis; counselling remains valuable because of what it says about the humane intentions of medical care. The practice of medicine cannot be driven by the evidence and rules of scientific inquiry alone. The doctor is not a clinical experimenter, but a healer. It is not only the provenance of change that is important but the openness with which that provenance is disclosed and discussed.
Change based on the vagaries of fashion is much less persuasive than change based on sound evidence. Fashion has played an important part in the development of twentieth century general practice. For the past 20 years primary care team work, educationalism (including role play and video consultation analysis), screening, health promotion, and performance review have all been fashionable. Although each of them has enhanced the character and complexity of modem British general practice, they were first and foremost fashions, with relatively short life spans. Most of them were driven by a small number of proselytising advocates (indeed one of us cannot be exonerated from much of this). In so far as the spread of the fashion has been experienced as growth and enlightenment, the changes were acceptable. But there remains the sense of being a slave to fashion. The violence of that term may explain much of the resentment and disdain expressed by general practitioners for the relatively innocent enthusiasms of academic bodies like the Royal College of General Practitioners.
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